Cargando…
Targeting protein tyrosine phosphatases for CDK6-induced immunotherapy resistance
Elucidating the mechanisms of resistance to immunotherapy and developing strategies to improve its efficacy are challenging goals. Bioinformatics analysis demonstrates that high CDK6 expression in melanoma is associated with poor progression-free survival of patients receiving single-agent immunothe...
Autores principales: | Gao, Xueliang, Wu, Yongxia, Chick, Joel M., Abbott, Andrea, Jiang, Baishan, Wang, David J., Comte-Walters, Susana, Johnson, Roger H., Oberholtzer, Nathaniel, Nishimura, Michael I., Gygi, Steven P., Mehta, Anand, Guttridge, Denis C., Ball, Lauren, Mehrotra, Shikhar, Sicinski, Piotr, Yu, Xue-Zhong, Wang, Haizhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544673/ https://www.ncbi.nlm.nih.gov/pubmed/37000627 http://dx.doi.org/10.1016/j.celrep.2023.112314 |
Ejemplares similares
-
New Developments in T Cell Immunometabolism and Implications for Cancer Immunotherapy
por: Oberholtzer, Nathaniel, et al.
Publicado: (2022) -
A phosphatase threshold sets the level of Cdk1 activity in early mitosis in budding yeast
por: Harvey, Stacy L., et al.
Publicado: (2011) -
Unexpected Outcomes of CDK4/6 Inhibition
por: Choi, Yoon Jong, et al.
Publicado: (2013) -
Sequential Cdk1 and Plk1 phosphorylation of protein tyrosine phosphatase 1B promotes mitotic cell death
por: O'Donovan, D S, et al.
Publicado: (2013) -
A kinase of many talents: non-neuronal functions of CDK5 in development and disease
por: Sharma, Samanta, et al.
Publicado: (2020)